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1. Introduction      
All those concerned with the decision-making, they take better decisions when they use all 
the available information with practical and interpretable way. Statistics provide methods 
for data collection and analysis to support the decision-making. 
Statistics is the Science of collection, analysis and interpretation of observed data reported in 
attributes of natural or social phenomena. Utilization of statistical methods included in the 
content of Statistical Science, allows the collection, classification, presentation and analysis 
of data. The statistical methods are objective and have mathematical background and 
formulation. 
The term population in the Statistics (Dodge, 2008; Everitt & Howel, 2005; Salkind, 2007) 
implies enumerations or measurements reported in a collection of beings or objects. A 
sample is a limited number of units and is extracted from the population under study 
according to the rules placed by the theory of sampling. The term data collection involves 
the process of measurement or enumeration of attributes of units of the population. 
In Statistics two sectors are included (Dodge, 2008; Everitt & Howel, 2005; Salkind, 2007), 
the Descriptive Statistics and the Inferential Statistics. Descriptive Statistics provides the 
systematic, quantitative description of natural, social and other phenomena. Descriptive 
statistics involves the study as well as the presentation, with more convenient way, of the  
data that exhibit features and behavior of these phenomena. Inferential Statistics has as 
subject the generalisation of conclusions that follow from the descriptive statistical data 
analyses performed in a representative sample, despite the existence of sampling errors, the 
margin of which is determined by the statistical induction at the generalisation. 
This study attempts to provide answers regarding various questions. It presents the 
framework of statistical studies in Telemedicine and describes the statistical methods used 
in Telemedicine research and evaluation (diagnostic tests, quality control, reliability 
analysis, sensitivity analysis, multivariate analysis, statistical pattern recognition and meta-
analysis). It also exploits the potential of statistical use in testing capacity/overall 
performance, reliability/endurance and scalability/benchmarking of a web based 
telemedicine platform with different numbers of simulated users for a user-defined time 
and presents vulnerability statistics available for testing the security of a web based 
Telemedicine platform. It also describes questionnaire based statistics for the evaluation of 
patient’s satisfaction and the contribution of statistics in new bio-markers detection. Further, 
qualitative and quantitative statistical techniques, regarding the electronic medical records 
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and bio-banks are also presented together with application based data analysis techniques 
(primary care, teleradiology, telecardiology, telepathology, teleoncology, teledermatology 
and home-telecare). Finally, the use of statistics in the design, evaluation and re-engineering 
of public telemedicine strategies is discussed. 
2. Organisation of statistical studies in Telemedicine  
Various types of statistical studies in health exist which can improve the implementation of 
Telemedicine. The basic characteristics of studies and their ideas are summarized as follows:  
• Need of understanding of disease causation 
• Need of description of disease occurrence 
• Utilization for creation and hypothesis testing and evaluation of Telemedicine and e-
Health interventions.  
Fundamental characteristics of designing studies for statistical data processing in 
Telemedicine are the creation of aims and objectives and the adoption of appropriate 
methodology. The Epidemiologist (Fig. 1) studies the models of diseases development and 
the factors that influence these models. 
 
 
Fig. 1. Synopsis of types for Epidemiological research 
The foundations of Epidemiology (Porta, 2008; Gordis, 2008; Rothman et al., 2008) are based 
on disease models, methods and approaches. Various epidemiological methods were 
developed at the pursuit of reasons of infectious diseases and epidemics. Epidemiology has 
also been proved effective in the localization of cross-correlations of cause-effect in non-
infectious diseases as the use of narcotics, the suicide, the car accidents, the chemical 
poisonings, the cancer and the cardiopathies. Other advanced research sectors are 
Epidemiology of chronic diseases and behavioral Epidemiology. 
As exploratory process, the Epidemiology constitutes the basis of public health and 
preventive medicine. It is used for the needs analysis for programs for diseases control, for 
the growth of prevention programs, for the planning of activities of health services and the 
identification of characteristics for endemic diseases, epidemics and pandemics. 
Designs for epidemiologic research (Porta, 2008; Gordis, 2008; Rothman et al., 2008) are 
Descriptive and Analytic. 
The aim of a descriptive design is the description of patterns and trends. These designs 
support the hypothesis formulation and the programme design. They determine the 
prevalence of a disease or the appearance of some other health outcome. They measure also 
risk factors and consequences in health outcomes. The risk factors and the consequences can 
be measured in connection (as a function) with the time. 
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The types of descriptive designs are (Abramson & Abramson, 2008; Abramson & Abramson, 
2001; Porta, 2008; Gordis, 2008; Rothman et al., 2008): 
- Case Report: the profile (model) of a patient is presented in detail from one or more 
clinical doctors. 
- Case Series: a collection of cases is created by a case report that has been extended to 
include a number of patients with a given disease. 
- Surveillance Report: The following stages are followed (i) data are collected with a 
standardized way for a disease as well as demographic elements, (ii) data collections 
are available (individual level) for a whole population, (iii) the appearance of a disease 
is examined per person, area and time. Systematic (a-priori) comparison of groups is not 
performed. The annual percentages or annual rates are many times attractive for the 
presentation of a tendency in connection with the time.  Often the accumulative use of 
case reports is indicative of a new epidemic or a new disease. 
- Ecological Studies: In these studies, all the population constitutes the object of analysis. 
The goal is to examine the ecological fallacy. 
- Correlation Studies: They are comparable with ecological. The aim is to discover the 
power of the ecological cross-correlation. 
- Cross-sectional Studies: Often, the interest of research is focused on the description of 
frequency and model or disease, or on a health-related outcome. The existing 
characteristics concern morbidity or some health related outcome and are measured 
simultaneously. Usually the collection of elements is realized via door-door visits, 
postal mail or with telephone interviews. There is no preselection of the cases or 
comparison groups (if they exist); post-hoc selection is realized. 
The goal of an analytic design is to test the hypothesis of a relation existence between a risk 
factor and a disease or a health outcome. A measure of the association is selected, and the 
magnitude, the precision, and the statistical significance of the relationship are determined. 
The types of analytical designs are (Abramson & Abramson, 2008; Abramson & Abramson, 
2001; Porta, 2008; Gordis, 2008; Rothman et al., 2008): 
- Cross-sectional studies: Apart from their descriptive use, sometimes are analytic. 
Preliminary selection of cases or comparison groups is not realized. Existing 
characteristics concern exposure or health outcome and are measured simultaneously. 
Consequently, the assessment of provisional result (temporality) in a relationship, 
which is revealed, is not possible. 
- Observational studies: In this category, longitudinal studies are included.  In a longitudinal 
study, the subjects are monitored in time with continuous or repeated follow-up of risk 
factors, health outcomes or both.  The two types of longitudinal studies are (i) Case-
Control: At this study, a population of cases and controls is selected that are comparable. 
The exposure or the risk factor between cases and controls is retrospectively measured. 
The exposure and the health outcomes are compared, between cases and controls, to 
test an a-priori hypothesis. (ii) Cohort or Follow up: The risk factor is measured to 
determine the exposed and non-exposed. This cohort is monitored in time, to find out 
the health outcome (morbidity). The a-priori hypothesis is tested at the end of the study 
period. (iii) Intervention Studies: In epidemiological research, the following designs can 
be applied: Clinical Trials, Field Trials and Intervention Trials. 
There is software for epidemiological research design such as EPIINFO and WINPEPI 
(Abramson & Abramson, 2008; Abramson & Abramson, 2001) that are proposed to be used 
for the organization of statistical studies in Telemedicine. 
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3. Statistical methods used in Telemedicine research and evaluation  
3.1 Power and sample size 
An important issue in a statistical study is the determination of the appropriate sample size 
(Whitley & Ball, 2002d) needed to test a null hypothesis. 
The effect size represents the magnitude of the effect and is usually known from previous 
research or specified from the researcher. Conventional values for effects have been 
suggested by Cohen (Borenstein et al., 2001). Alpha is the criterion required to establish 
statistical significance (usually set at 0.05). 
The power (Whitley & Ball, 2002d) is the probability to detect and call significant the 
specified effect at the designated level of significance. As a general standard, power should 
be set to 80%. The higher the specified power (usually set between 80% and 95%), the larger 
the sample size. 
Software is available to determine the sample size given the power, alpha and effect size and 
selecting the statistical analysis we want to apply. Note that when working with drugs and 
the study goal is to obtain FDA approval for use, then alpha should be set to 0.01, while 
keeping power at 95% (Borenstein et al. 2001). 
Power and Precision, NQUERY Advisor, GPOWER, WINPEPI, SAS, NCSS-PASS can be 
used for the determination of power and sample size. 
3.2 Diagnostic tests  
Diagnostic tests or Screening tests are called the medical tests performed to detect and prevent 
diseases. These tests are the series of annual medical check-ups, blood tests, test Pap and 
various x-rays. Their goal is to detect diseases that cannot be detected with other way or for 
the discovery of a disease in premature stage (before the appearance of symptoms) to 
handle it in time and effectively. A characteristic of diagnostic tests is that if an individual 
has a positive outcome then it is probable to have the disease under investigation and 
consequently is submitted in more precise examinations or straight therapy (if the 
diagnostic test is extremely precise). In these cases, Bayes theorem is particularly beneficial. 
The positive predictive value of a diagnostic test is the probability of someone to be patient 
when the diagnostic test is found positive. The negative predictive value of a diagnostic test is 
the probability of someone not to be patient when the diagnostic test is found negative. False 
negative case is an individual who has the disease, but the diagnostic test is negative. When 
the individual does not have the disease, but the diagnostic test is positive we have a false 
positive case. In a study, we usually observe sensitivity and specificity. Sensitivity of a 
diagnostic test (or symptom) is the probability the test to be positive (or the symptom to 
appear) given that someone has the disease under investigation. Specificity of a diagnostic 
test (or symptom) is the probability the test to be negative (or the symptom not to appear) 
given that an individual does not have the disease under investigation. Both values should 
be high and close to one to have a suitable diagnostic test. 
Usually, the measurements of diagnostic tests are performed using quantitative scale 
variables. In this case, we are interested in the cutoff point over which we consider that the 
test is positive (the point above which there is increased probability for the appearance of a 
disease).  To select the cutoff point, we use ROC (Receiver Operating Characteristic) curve. 
A ROC curve (Bewick et al. 2004f) presents in a curve the combinations of false positive 
cases (1 − specificity) and sensitivity (in X and Y axes) for all the values observed in a 
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sample. Appropriate values as cutoff points are the values that are close to diagram's  upper 
left corner  (these have low count of false positive cases and high sensitivity). 
Consequently ROC curves (Bewick et al. 2004f) are the graphical representation of the 
characteristics of a quantitative diagnostic test and help us to examine test performance for 
different points of a prognostic test.  An important value in ROC curves is AUC (Area 
Under Curve). AUC measures the probability the value of a test for a patient to be higher 
from the value of a test for an individual without the under investigation disease. Of interest 
is the test of hypothesis H0: AUC = 0.5 with alternative H1: AUC > 0.5. The value AUC = 0.5 
corresponds to a test that guesses randomly and has no prognostic ability. 
WINPEPI,  Stata, SPSS, NCSS, MedCalc, etc. can be used for the calculation of sensitivity 
and specificity and for ROC analysis. 
3.3 Statistical quality control  
Statistical quality control (Montgomery, 2004) is the collection of all methodologies that in 
collaboration with the management and marketing allows improving the productive 
process. A definition of quality with statistical meaning is: “a product or a service is of 
quality if it is adapted to the user requirements and is improved when its variability is 
minimized”. Quality is also connected with a large number of characteristics that are related 
to whether the product will do the work for which it is intended, the reliability, etc. (Juran & 
Blanton Godfrey, 1999; Russel, 2000). Statistical quality control is constituted by three 
sectors: acceptance sampling, statistical process control and design of experiments.  
Each productive process, independently of how well it is designed has a percentage of 
variability. This variability is the summation of variability of many small causes that are 
difficult to avoid. This variability is referred as a common form of variability, and a system 
that works with only the presence of this variability is considered to be under control. In a 
process also, other forms of variability may be present. These forms are mainly due to one of 
the following reasons: (i) erroneously regulated medical equipment, (ii) errors of medical 
equipment operator. These forms of variability are those that cause a process not to be under 
statistical control. 
Telemedicine units should adopt the principles and administration of total quality 
management (Juran & Blanton Godfrey, 1999; Russel, 2000) and include the 5Qs: quality 
planning, quality laboratory process, quality control, quality assessment and quality 
improvement. 
QI Analyst 3.5. by SPSS, SAS Quality Improvement, STATIT Quality Control First Aid Kit, 
STATISTICA, MINITAB 16, NCSS can be used for Statistical Quality Control.  
3.4 Reliability statistics  
The consistency of a collection of measurements is called reliability (Koran, 1975a; Koran, 
1975b).  Regarding its assurance in Telemedicine studies, four classes of reliability estimates 
exist (Dodge, 2008; Everitt & Howel, 2005; Salkind, 2007), all examining the variation of 
measurements.  
Measurements can be taken, with the same method or instruments, by different observers 
(inter-rater reliability), or by a single observer under the same conditions (test-retest 
reliability including intra-rater reliability). Inter-method reliability deals with measurements 
derived using different methods or instruments on the same individual. Internal consistency 
reliability deals with the consistency of measurements across items within a test. 
WINPEPI can be used for the calculation of reliability statistics (Fig. 2). 
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Fig. 2. Reliability statistics  
3.5 Sensitivity analysis  
Sensitivity analysis exploits the degree in which the conclusions can change if the values of 
the key variables or hypotheses statements change. 
As examples, the following can be applied in Telemedicine: 
The user may want to examine how power is affected changing the values of effect size, 
sample size and alpha. This analysis is provided using as software the GPower or Power 
and Precision. 
Financial projections may show the effect of different hypotheses related to the expenses for 
telecommunications and other resources. A special problem in the evaluation of 
Telemedicine is the stability of the technology or the environment. With the technologies of 
data collection, communication and presentation aiming to improve healthcare quality 
simultaneously reducing cost, the evaluators may focus on (i) how sensitive the results may 
be in technological change, (ii) how to design the analysis to assess the impact of changes. 
A cost-benefit analysis can include a sensitivity analysis that incorporates different 
hypotheses about the time and the cost of improvements or replacements in hardware or 
software (Briggs et al., 1994; Hamby, 1995). 
3.6 Hypothesis testing  
The Inferential Statistics are the sector of applied statistics that deals with the generalization 
of the descriptive statistics conclusions in the population. 
Hypothesis testing is the effort of estimating unknown population parameters using samples, 
realizing the testing of concrete hypotheses about the under investigation population 
parameters. More analytically, the problem faced is how from the data of a sample, we can   
decide if a hypothesis must be rejected in the population. After the selection and the 
determination with clarity of the problem under investigation, what follows is the 
formulation of the hypothesis that is to be checked.  
The hypotheses under consideration are not proved with testimonies, only they cannot be 
denied. In the hypotheses involved in a research study, some hierarchy can exist. Often, for 
the initial hypothesis the expression inquiring is used, while, for the one that results in the 
end, the term functional is used. The hypothesis should be solid and relatively easy in the 
testing. General hypotheses are not recommended. The hypotheses should not be 
incompatible with things that are already known and should be based on the existing 
knowledge.  
The ways of a hypothesis formulation are an  important point in the statistical analysis. We 
do not check the functional hypothesis, but the logic of the opposite one called the null 
hypothesis. In the case that the null hypothesis is rejected, then we accept the alternative 
hypothesis. The null hypothesis we usually denote it with Η0 and its alternative with Η1. 
The results of a decision that will be taken in significance level alpha in connection with 
what happens in the population are presented in the following Table 1. 
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True Η0  
(Null Hypothesis) 
False Η0  
(Null Hypothesis) 
Η0 Null Correct Decision Error type ΙΙ 
Η1 Alternative Error type Ι Correct Decision 
Table 1. Correct decision and error types in statistical hypothesis testing process 
As error type Ι, we define the probability to reject Η0 while this is in effect. This error is also 
called significance level alpha of the test. As error type ΙΙ, we define the probability to accept 
Η0 while this is not in effect. In each test, what is of interest is to reduce error type Ι. 





Fig. 3. Decision tree for the statistical analysis of two variables 
Statistical data analysis principles (Matthews & Farewell, 2007; Bowers, 2008; Harris & 
Taylor 2003) are available in the form of reviews (Whitley & Ball, 2002a; Whitley & Ball, 
2002b; Whitley & Ball, 2002c; Whitley & Ball, 2002e; Whitley & Ball, 2002f; Bewick et al., 
2003; Bewick et al., 2004a, Bewick et al., 2004b; Bewick et al., 2004c; Bewick et al., 2005). 
Various statistical packages are available to test a hypothesis involving two variables or for 
multivariate analysis:  STATISTICA, SPSS, SAS, NCSS, MINITAB, StatView, Medcalc, Stata, 
BMDP and StatXact with Cytel Studio (non parametrics). 
3.7 Multivariate analysis 
In most cases, many variables are involved in the statistical analysis (Stevens, 2002; Rabe-
Hesketh & Everitt, 2007; Landau & Everitt, 2004). Depending on the measurement scales of 
the data various data analysis options are available (Fig. 4).  
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Fig. 4. Statistical techniques for multivariate data analysis 
3.8 Statistical pattern recognition 
Statistical pattern recognition is concerned with discrimination and classification both 
supervised and unsupervised (Webb, 2002). Two related approaches to supervised 
classification are the estimation of probability density functions and the construction of 
discriminant functions. There are also nonlinear models (projection-based methods) and the 
decision-tree approach to discrimination. Unsupervised classification or clustering is the 
process of grouping to discover the presence of structure. Statistical methods are also used 
in feature generation and feature selection (Theodoridis & Koutroumbas, 2009; Webb, 2002). 
Statistical pattern recognition has application in biosignal processing and medical image 
analysis.  
Various statistical packages are available for discriminant analysis such as NCSS, SPSS, 
STATISTICA, and BMDP. For clustering, statistical packages are BMDP, Stata, NCSS, 
Statistica, SPSS, etc. A significant Statistical Pattern Recognition Toolbox (STPRTOOL) has 
been developed for MATLAB (Frank & Hlava, 2004). 
3.9 Meta-analysis 
Meta-analysis allows for general inspection of evidence for clinical problems and necessary 
with the exponential increase of information in medicine (Borenstein et al., 2009). Meta-
analysis uses data from many different studies that deal with the same subject. This allows 
(i) the calculation of a total/ concise result from all the studies called pooled effect, (ii) 
extensive detection of systematic errors and calculation of differences (heterogeneity). Meta-
analysis uses objective quantitative mathematical methods to summarize study data. Meta-
analysis can be used in studies that are (i) empirical rather than theoretical, (ii) contain 
quantitative results, (iii) investigate the same relationships, (iv) results are presented with 
the same comparative statistical manner and (v) are comparable for the main question.  
Explicit criteria of studies choice and rejection are needed.  Wide inquiring fields require 
detailed criteria. Strict criteria create a problem of generalization of results and relaxed 
criteria create a problem of results reliability. The study of fixed effects (results of different 
studies differ only from chance) is conducted using the Mantel-Haenszel method, and the 
study of random effects (results are not homogeneous) is conducted using DerSimonian & 
Laird method. Heterogeneity is tested using Cochran Q or the indicator of inconsistency 
(Higgins et al., 2003). 
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Statistical packages available are: RevMan (Cochrane), STATA (metan), SPSS (using 
macros), R (rmeta), Comprehensive meta-analysis and Meta-analyst. 
4. Commonly used statistical methods in Telemedicine diagnosis  
4.1 Analyzing validity  
An ideal research technique is characterized from validity which means that it measures 
correctly what has to be measured (Dodge, 2008; Everitt & Howel, 2005; Salkind, 2007). 
Sometimes, an established framework is defined to determine the validity of a method.  In 
the practice, therefore, the validity should be examined indirectly. Usually two ways are 
used. A technique, which has been simplified and standardised in order to be suitable for 
use in research, can be compared with the best conventional clinical examination.  
Alternative a measurement can be evaluated from its ability to predict a future disease. 
Examining validity through prediction ability may require the existence of many subjects in 
the study. When the purpose of a research or a test is based on the separation of subjects 
(e.g. as cases or controls, exposed or not exposed), validity is analyzed classifying the 
subjects with positive or negative outcomes, on the basis primarily of the research method 
and secondarily with the typical control test. A contingency table can be derived with the 
true positive, true negative, false positive and false negative outcomes. From this table 
sensitivity, specificity, systematic error and predictive value can be calculated. 
4.2 Analyzing repeatability  
Repeatability analysis (Salkind, 2007) can be organized as a separate study, for example, a 
sample of individuals with a second examination, or x-ray samples checked twice. Even a 
small sample can be reliable if (i) it is representative and (ii) duplicate tests are independent.  
If repeatability analysis is performed as a part of a pilot study, then care is needed to ensure 
that the subjects, the observers and the working conditions are representative of the main 
study. Repeatability is easy to be checked when the material can be transferred and stored 
(e.g. histologic samples and medical images). Repeatability analysis is useful when there is 
no acceptable standard to assess the validity of a measurement. Poor repeatability usually is 
related with poor validity or indicates that the measured characteristic is differentiated in 
time. In both cases, the results should be interpreted carefully. It is stressed that repeatable 
discoveries do not guarantee that the method that was used is valid. Repeatability can be 
checked from the same observer (realizes the measurement in two separate cases) and 
between observers (with comparison of measurements that became from different observers 
in the same subject). The repeatability of measurements for scale variables can be 
summarized with the standard deviation of the repeated measurements or with the 
coefficient of variation. The pairs of measurements from the same observer or different 
observers, the extent and the divergence can be presented in a scatterplot. For qualitative 
characteristics, such as clinical symptoms and indications, the results are initially presented 
in a contingency table (with the true positive, true negative, false positive and false negative 
outcomes) and then Kappa statistic is calculated. The minimal value of the Kappa statistic is 
less than zero (poor repeatability) and the highest is one (perfect repeatability). 
4.3 Using statistics to serve clinical objectives  
A Telemedicine program may have different outcomes that are proportional to the 
population under study and the health status of the specific group during the application 
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time. The type and health status of the application group have direct repercussions both in 
quality and the access possibility of a patient.  Proportional are also benefits from the 
reduction of patient cost of care. 
The plan is to collect data regarding: (i) standard and variable program costs, (ii) use of 
services from the participating patients, (iii) demographic characteristics of patients and 
clinical history, (iv) presentation of symptoms and complaints, (v) health status, (vi) 
symptoms risk, (vii) operational capability, (viii) analysis of symptoms, and (viiii) 
characteristics of the teleconsultations. 
In clinical level the following items should be recorded and evaluated: 
• Demographic characteristics of patients and their clinical history. 
• Symptoms of present disease. 
• Evidence of reliable transmission and evaluation of data acquired from the physical 
examination of patients and the parameters acquired from telemedicine medical 
devices. 
• Use of telemedicine services from the patients and recording of medical problems 
during program use. 
• Changes in the ways of patient access (number of teleconsultations, teleconsultation 
type, and cost of diagnostic examinations). 
• Changes in patient treatment with evaluation of the changes in the pharmaceutical 
treatment (change of drug, dose and the way of issuing of pharmaceutical substances, 
cost of these changes) and the therapeutic methods used (number, type and cost of 
chirurgical interventions). 
• Changes in the medical or nursing visits, number of hospitalizations (morbidity) and 
mortality of patients. 
• Improvement of quality of life and mental health of patients with the use of special 
questionnaires. 
5. Statistics in testing the performance of a Web-based Telemedicine 
platform   
There is the potential of statistics use (Fig. 5) in testing, capacity/overall performance, 
reliability/endurance and scalability/benchmarking of a web based telemedicine platform 
with different numbers of simulated users for a user-defined time. 
 
 
Fig. 5. Statistical measures of performance in Web-based Telemedicine platforms 
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Software that is proposed to be used is WAPT 6.0 and NEOLOAD. 
Furthermore, in the Telemedicine network, each computer and  medical device reliability 
and history should be  continuously monitored regarding application failures, operating 
system failures, various other failures and warnings. 
6. Statistics in testing the security of a Web-based Telemedicine platform   
The percent of various security vulnerabilities (Web Application Security Consortium, 2008) 
in time (on a daily basis diagram) should be monitored for a web based telemedicine 
platform (Fig. 6). 
 
 
Fig. 6. Common security vulnerabilities in Web-based Telemedicine platforms 
Software that can be used to produce security audits for Web based Telemedicine platforms 
is Acunetix. 
7. Questionnaire based statistics for the evaluation of patient satisfaction    
Herein, the strategy and the steps to get valid comparative data and analyze it, are 
presented. 
Three types of questionnaires can be used: to the patient, to the provider and to the 
organization. 
The questionnaires should be valid and reliable. In a questionnaire creation process, it is 
necessary to determine the reliability (internal consistency) of the new instrument. It is 
difficult to assess the quality of data collected during a research process. It is easier to 
evaluate the accuracy of the research tool used for data collection. This assessment is 
comprised by the analysis of validity and reliability.  Each stakeholder class (patient, 
provider, organization) has expectations and satisfaction sentiments for the quality of 
information, services and operations which are offered. The goal is to identify the most 
significant factors that cause the highest level of dissatisfaction and have the bigger effect 
with respect to e-healthcare quality and the costs. 
A method to test questionnaire validity: When the factors that produced the highest level of 
dissatisfaction are derived, using a questionnaire, a representative sample of each category 
stakeholder can be interviewed and asked to complete a new short questionnaire. This 
research will determine how appropriate, complete and comprehensive are the questions in 
a group of evaluators that have certain knowledge of the content. This process allows 
confirming questionnaire validity. 
A method to test questionnaire reliability: To evaluate the reliability level of the questionnaires 
different methods can be used (test-retest method, split halves method). The reliability of 
internal consistency can be measured calculating Cronbach’s coefficient alpha. An 
additional scale can be included to measure the questionnaire internal consistency. This 
scale can be defined with the characterization “satisfied/dissatisfied” and can be included in 
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the evaluation of each factor measuring quantitatively also the strength of the 
characterization (from poor to high).  This "direct" evaluation should be related with each 
factor score measured from the strength of characterization. The same scale can be included 
at the end of the questionnaire, to provide an evaluation of the stakeholder overall 
satisfaction with aspects for the Telemedicine system, services and information. These scales 
allow the selection and the representitaviness of the factors and their characterizations to 
evaluate stakeholder satisfaction for a telemedicine system. These added scales can be used, 
during experimental research, to validate the internal consistency of the questionnaire. 
Various multivariate statistical analyses can be performed on the questionnaires with focus 
on reliability analysis (for Cronbach’s alpha coefficient calculation) and exploratory and 
confirmatory factor analysis. 
Experimental processes to compare a Telemedicine treated group with an alternative, traditional care, 
group:  During the pilot study to evaluate a Telemedicine program, patients with a known 
disease should be included that are exposed to health risk justifying the need of 
telemedicine and the highest benefit from it. The patients should be divided in two groups: 
the telemedicine group and the control group.  The control group should be comprised from 
patients similar in age and sex and with the same disease and will receive regular traditional 
health monitoring (no telemedicine treatment). 
Data Analysis: All the data (electronic recordings of medical signals, images and text) should 
be collected in the electronic medical record and the specialized questionnaires be collected 
and stored in a database.  
The two groups of patients that participate in the study can be compared to find out if there 
are statistical significant differences in the following aspects: 
• The diagnostic access, from the recording of the number, the type and the cost of 
diagnostic examinations needed during the study period.  
• The therapeutic treatment from recording the changes in the pharmaceutical therapy 
using the drug type, the drug dose, the way of issuing the pharmaceutical substance, 
the cost of drug dose during the study period.  
• The chirurgical therapeutic methods needed, recording the number, the type of surgery 
and the cost of surgery during the study period.  
• The number and the cost of medical or/and other visits recorded during the study 
period.  
• The number of hospital admissions (morbidity) during the study period and the cost of 
hospitalization.   
• The number of patient deaths (mortality) during the study period.  
• Quality of life and mental health, using analysis on appropriate questionnaires.  
8. Exploit the use of statistics in new biomarkers detection  
A biomarker is a measurable factor that is associated with a medical condition (a gene 
variant, a metabolite, a pattern of gene activity, etc.). Drug development process is most 
benefited from biomarkers that allow the early detection, diagnosis, and prognosis of 
diseases. It is an enormous challenge to analyze using statistics ‘omics’ data (genomics, 
transcriptomics, proteomics, metabolomics, interactomics, regulomics) (Lee, 2010). 
A synthesis of available statistical techniques for new biomarkers detection is presented in 
Fig. 7.  
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Fig. 7. Statistics in analysis of ’omics’ data 
Statistical packages in bioinformatics available are R and Bioconductor. 
9. Qualitative and quantitative techniques regarding electronic medical 
records and biobanks 
9.1 Statistics regarding the electronic medical records  
Electronic medical records, apart from numerical measurements, also contain images, 
biosignals and text. Statistical analysis on numerical measurements (Fig. 3, Fig. 4), images 
(Fig. 8, Fig. 9), biosignals (Fig. 10), and text (Fig. 11), has already been applied. 
 
 
Fig. 8. Image measurements techniques (Russ, 1995) 
 
 
Fig. 9. Statistical image analysis techniques applied on image measurements 
For spatial statistical image analysis SpatStat library is available in R as well as the Image 
Processing Toolbox in MATLAB.  
Statistical packages that perform time series analysis on quantitative biosignal data are 
SPSS, NCSS, Statistica, SAS, Stata, BMDP, etc. 
www.intechopen.com




Fig. 10. Statistical analysis techniques applied on biosignals measurements 
It also exists specialized software for biosignal analysis including statistics such as 
g.Bsanalyze and SIGVIEW. 
For  qualitative analysis of the texts included in the electronic patient  records, NVIVO 
software can be used which allows after coding the extraction of relationships and the 
exploration of models produced. For mixed-model qualitative data analysis using coding, 
annotating, retrieving and analyzing small and large collections of documents and images in 
the electronic patient record, QDA Miner with WordStat & Simstat software can be used. 
 
 
Fig. 11. Statistical analysis techniques applied on text data 
9.2 Epidemiology using biobanks  
Biobanks are repositories of human biological material linked to clinical data (medical and 
lifestyle data) for evaluation of interactions between the environment and genes. The 
ultimate goal is to understand the disease development process. Biobanks are categorized in 
(i) prospective: biological material is collected at study start and health status is monitored 
over subsequent years, and (ii) retrospective: biological material from people who have 
already developed a disease is collected, over subsequent years, to track down the 
association between environment, genes and the diseases. 
The number of cases is essential for a reliable analysis.  Other points of interest are the 
quantification of metatada acquired and biobanks security auditing. The ultimate goal is the 
creation of an epidemiological meta-database using regulations, standardized methodologies 
and coordination across biobanks. Ethical considerations involved are (i) the privacy of the 
donor and (ii) who owns the samples. Informed consent of the donor is a pre-requisite in 
storing data (in a biobank), as well as the established policies from biobanks. 
There are various facilitations for epidemiology using biobanks (Fig. 12). 
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Fig. 12. Epidemiology using biobanks 
Clustering of disease 
Clustering of disease (Mantel, 1967; Manly, 1986) can be realized spatial, temporal and 
spatial temporal using data from electronic medical records. Spatial clustering of disease 
may be attributed to the population distribution, the relationship of disease with diet, the 
habits, the environment or the profession. Chi-square test can be used for statistical 
decision-making. Temporal clustering of disease may be attributed to seasonal variation, 
systematic trends or in rapid increases due to additional factors. Again, Chi-square test can 
be used for statistical decision-making. Spatial temporal clustering of disease concerns cases, 
where they are neighboring in the space (spatial) and simultaneously they are neighboring 
in the time (temporal) because of the existence of pestiferous factors, environmental 
episodes in regional scale or local immigrations. The main spatial temporal association in 
the appearance of a disease can involve the existence of certain infectious or environmental 
reasons. Mantel’s test is used for the control of space-time interaction (Manly, 1986). 
Quantification of disease frequency in populations 
Disease frequency measurement in populations requires the careful formulation of 
diagnostic criteria. It has also been observed that the morbidity in populations is presented 
as development of severity. The two measures of disease frequency are incidence and (point 
or period) prevalence.  Herein, we assume that the percentages in the exposed population are 
comparable with those of the unexposed individuals. Exposure can assess risk factors for 
which suspicions exist that they cause the disease (Bewick et al., 2004d). There are measures 
used to summarize the comparisons of morbidity percentages between populations: relative 
risk, attributable risk, population attributable risk, and attributable proportion. Most 
epidemiological studies are based on observation and compare persons that differ with a lot 
of ways, known and unknown. If the morbidity risk is determined by such differences 
varying from the exposure under consideration, then we can say that there is confounding 
of the classification factors (e.g. age and sex) in relation to morbidity. Confounding is 
handled using (i) (direct or indirect) standardization or (ii) mathematical modeling (e.g. 
logistic regression). 
Statistical measures of mortality  
Mortality is used to describe death as a disease outcome. Statistics are derived from data 
written in death certificates. In the published mortality tables, the actual numbers and the 
rates of death per sex, age and causality are presented. In clinical trials for diseases that lead 
to death the health outcome can be defined as case mortality or survival rate. Survival 
curves (Bewick et al., 2004e) can be drawn from the survival rates in different times. 
Incidence, prevalence and other measures  
The terms of incidence and prevalence have been defined concerning the presence of disease 
and can be extended to include other situations. Certain healthcare results do not necessarily 
describe incidence or prevalence. Alternatively, the following measures (related with a year) 
can be used: birth rate, fertility rate, infant mortality rate, stillbirth rate, and perinatal 
mortality rate. 
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Measurement errors and bias  
The epidemiological studies measure characteristics of the populations. The parameter of 
interest may be the morbidity percentage of a disease, the prevalence of an exposure and 
more often a measure of association between the exposure and disease.  Given that the 
studies are realised in human subjects and are conditioned by practical and ethical 
restrictions, the danger of bias exist. The possible cases of bias are (i) Selection bias: 
Selection bias is required to be examined when a sample is determined and in the cases 
the answers are not complete. (ii) Information bias: Bias also results from errors in the 
measurement of exposure or the severity of a disease. Bias can not be abolished entirely 
from epidemiological studies. The aim therefore is to ensure that it exists in a minimal 
degree, examining their possible impact and taking it into consideration when 
interpreting the results. The measurement errors in the exposure or the disease may be a 
valuable source of bias in epidemiological studies. Consequently at the implementation of 
research it is necessary to assess the quality of measurements. 
Useful statistical packages for epidemiological research that can be used are EPIINFO and 
WINPEPI. 
10. Telemedicine application based data analysis techniques 
Exploiting the fundamental telemedicine applications (primary care, teleradiology, 
telecardiology, telepathology, teleoncology, teledermatology and home-telecare) it is 
obvious that text, biosignals and images are transferred. For these data types, various 
statistical data analysis techniques can be applied in the electronic medical records (Fig. 8, 
Fig. 9, Fig. 10, Fig. 11) collected using Telemedicine. 
Furthermore, performance (Fig. 5) and security auditing statistics (Fig. 6) are required to be 
collected during monitoring of the telemedicine application and network. 
Statistics can be extracted also using data from teleconsultations and telediagnosis 
(presented previously as statistics used to serve clinical objectives) as well as from 
evaluating the patient’s and provider’s satisfaction (presented as questionnaire based 
statistics) using questionnaires. Another important feature for Telemedicine diagnosis 
processes is careful statistical reliability analysis (Abramson & Abramson, 2008; Abramson 
& Abramson, 2001; Koran, 1975a; Koran, 1975b). 
11. Statistics use in the design and re-engineering of public Telemedicine 
strategies 
In the current era of Telemedicine and e-Health, all nations are interested in developing 
national strategies for the improvement of quality and reliability of Telemedicine. Material 
provided by WHO (World Health Organization, 2006a; World Health Organization, 2006b) 
can be used as effective assistance to this effort. Legal frameworks regarding the 
implementation of Telemedicine within a country as well as in trans-border care should be 
taken into account in this process accompanied with ethical issues, issues related to patient 
safety, patient empowerment and evaluation.  
Statistical quality control can be used in the design and re-engineering of Public 
Telemedicine strategies. Statistical analysis of teleconsultations information and electronic 
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medical records (including genomic information) collected practising Telemedicine and e-
Health provides enormous possibilities in decision-making (Fig. 13) and in facilitating 







Fig. 13. The contribution of Statistics in Telemedicine 
12. Conclusion 
There was a lack in the scientific literature regarding a systematic presentation of statistical 
methods in Telemedicine. This work uncovered opportunities and challenges related to the 
contribution of statistical data processing in Telemedicine. It is our hope that the guidelines 
presented herein, in the form of concept maps, will serve as telemedicine assessment 
instruments for the improvement of Telemedicine systems and services. Future work will be 
focused on producing detailed statistics review frameworks for all Telemedicine 
applications accompanied with case studies. 
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